1 / 24

Global Classrooms

Global Classrooms. Topic and Country Assignments. Our Countries are…. Togo Azerbaijan Congo Lebanon El Salvador.

ossie
Download Presentation

Global Classrooms

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Classrooms Topic and Country Assignments

  2. Our Countries are… • Togo • Azerbaijan • Congo • Lebanon • El Salvador Source: http://www.google.es/imgres?imgurl=http://geology.com/world/world-map.gif&imgrefurl=http://geology.com/world/world-map.shtml&h=715&w=1200&sz=98&tbnid=WyeCmd4K74fpMM:&tbnh=90&tbnw=151&zoom=1&usg=__hKLt0UL3_I_m9lGzOEBIP_MoqIk=&docid=19EM_yJbKFXQIM&sa=X&ei=f1RxUvr7IMvH7AbK-4GADQ&ved=0CDcQ9QEwAQ

  3. Where are they? Source: http://www.google.es/imgres?imgurl=http://geology.com/world/world-map.gif&imgrefurl=http://geology.com/world/world-map.shtml&h=715&w=1200&sz=98&tbnid=WyeCmd4K74fpMM:&tbnh=90&tbnw=151&zoom=1&usg=__hKLt0UL3_I_m9lGzOEBIP_MoqIk=&docid=19EM_yJbKFXQIM&sa=X&ei=f1RxUvr7IMvH7AbK-4GADQ&ved=0CDcQ9QEwAQ

  4. Africa: Togo and Congo

  5. Central America: El Salvador

  6. The Middle East: Lebanon and Azerbaijan Source: http://www.infoplease.com/atlas/middleeast.html

  7. The Groups are… • Togo: María, Lorena, Alberto • Azerbaijan: Andrea, Wisal, Adrián • Congo: Vivian, David, Jesus • **Let me clarify which Congo and I will let you know via email • Lebanon: Elisa, Adán, Irene • El Salvador: Alvaro, Manuela, Christian, Patricia

  8. Our Conference Topic Is… • GENERIC DRUGS • UN Committee: World Health Organisation (WHO) Source: https://d3ojdig7p1k9j.cloudfront.net/wp-content/uploads/2013/08/generic-drugs.jpg

  9. World Health Organisation • Agency of the UN that provides leadership on global health matters • Has 194 member nations • Provides support and information on issues like food safety, HIV/AIDS, maternal health and scientific research Source: http://www.puntlandi.net/?p=430

  10. Generic Drugs • “A pharmaceutical product usually intended to be interchangeable with an innovative product that is manufactured without a license from the innovator company and marketed after the expiration date of the patent or other exclusive rights.”

  11. Patents • “A title granted by public authorities that confers a temporary monopoly for the exploitation of an invention on the person who registers it, furnishes a sufficiently clear and full description of it and claims this monopoly.” • Forbids others from using the invention without the inventors’ permission • Drug patents are usually in effect for 17-20 years • After this period, other companies can produce and sell the drug without permission: AKA generic drugs • Same chemical formula as the expensive major brand but at a much cheaper price

  12. How are Generic Drugs Made and Why are they so Cheap? • Major pharmaceutical companies put a lot of money into research and development of the drug and therefore charge a lot of money • Generic drug companies have the chemical formula already available to them (no R&D) and do not have to worry about the expensive and time-consuming regulatory testing. Thus they do not need to charge as much money to make money.

  13. Why do we care? • Generic drugs are cheaper and therefore allow impoverished people to access drugs • 8 million people in low and middle-income countries currently receive drugs for HIV/AIDS which would not be possible without generic drugs

  14. But then what is the problem? • Impoverished people need cheap generic drugs, but major pharmaceutical companies need to make money in order to research and develop drugs. • If they can’t make money  No drugs • No drugs  No treatment

  15. The Road to Becoming a Drug • A need is determined • Research is done to find the best chemical formula (usually on the cell or protein level) • The drug is put through a series of regulatory tests assigned by the government for the safety of people • Cells  Animals  Human Trials (Clinical Trials) • If the drug passes all the tests it can then be patented • The drug can then be sold to consumers

  16. On the Political Level • In 1994 the World Trade Organization protected big pharmaceutical companies via the TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement • However, a country could override the patent protection by issuing a “compulsory license” when they were in the midst of an epidemic

  17. On the Political Level • However, many countries began to abuse their compulsory licenses • Ex. Thailand in 2006 was not able to negotiate a cheap enough price with Pharm companies and issued a compulsory license for cancer drugs • Diseases like Cancer, Diabetes, and Heart Disease are known as non-communicable diseases as they are not passed from person to person. • Again, Big Pharma companies need the money to do research and development of new drugs

  18. Current Situation • Generic Drug production is increasing • Research and Development costs are increasing • Big Pharma companies have introduced tiered pricing based on their clients income level • Helps low income countries but not middle income countries • Main problem surrounds HIV/AIDS drugs, whose patents are quickly expiring and which are expertly produced at low prices in countries like India

  19. Further Problems • Many second line drugs (newer versions of the drug with less resistance or toxicity) are still under patents and impoverished countries must rely on older, less effective methods • While countries like the United States have put forth a lot of effort into making sure poor countries have access to HIV/AIDS drugs, they have also increased patent protection on non-communicable disease drugs. They argue that cancer and diabetes are less of an emergency than HIV/AIDS, malaria, and TB.

  20. Source • Global Classrooms. “World Health Organization (WHO), Topic: Generic Drugs.” Global Classrooms 2013. Print.

  21. So things to keep in mind: • Big pharma expenses versus profits • Need for cheap drugs versus need for expensive drugs that fund future research • Tiered pricing pros and cons

  22. Country Presentations • NEXT THURSDAY • 10 MINUTES (and no more!) • Citations! • I WILL NOT ACCEPT LATE PRESENTATIONS! • Everyone must speak

  23. Country Presentations • What you should include • Government (Government system, Head of State, Languages) • Economy (GDP, Economic System, Development classification, import/exports, natural resources) • People (Religions, growth rate, standard of living) • Military • UN Relations (Has the UN had to intervene in a country conflict?) • Relations with WHO and what you think is the country’s position on the generic drugs debate

  24. Research Aids • WHO Website • UN Website • Allcountries.eu • Council on Foreign Relations (cfr.org)

More Related